CA Patent

CA3056923A1 — Drugs and compositions for the treatment of ocular disorders

Assigned to Calcimedica Inc · Expires 2018-09-27 · 8y expired

What this patent protects

The present invention provides new prodrugs of therapeutically active compounds, including oligomeric prodrugs, and compositions to treat medical disorders, for example glaucoma, a disorder or abnormality related to an increase in intraocular pressure (IOP), a disorder requiring …

USPTO Abstract

The present invention provides new prodrugs of therapeutically active compounds, including oligomeric prodrugs, and compositions to treat medical disorders, for example glaucoma, a disorder or abnormality related to an increase in intraocular pressure (IOP), a disorder requiring neuroprotection, age-related macular degeneration, or diabetic retinopathy.

Drugs covered by this patent

Patent Metadata

Patent number
CA3056923A1
Jurisdiction
CA
Classification
—
Expires
2018-09-27
Drug substance claim
No
Drug product claim
No
Assignee
Calcimedica Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.